MedTrace Logo

Effect Of Dexmedetomidine On Sublingual Microcirculation In Patients Undergoing On Pump CABG Surgery

NCT02714725 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2018-01-24

No results posted yet for this study

Summary

This study is designed to explore the possible effects of dexmedetomidine infusion on sublingual microcirculation in patients undergoing on-pump coronary artery bypass graft surgery

Conditions

  • Sublingual Microcirculation

Interventions

DRUG

Dexmedetomidine

During bypass, patients will receive dexmedetomidine infusion 0.5 mcg/kg/hr

DRUG

Placebo for Dexmedetomidine normal saline infusion

During bypass, patients will receive normal saline infusion

DRUG

Propofol infusion

During bypass, patients will receive propofol infusion 50 - 70 mcg/kg/min

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hisham H Abdel Wahab, MD · Cairo University

  • Hossam S El-Ashmawi, MD · Cairo University

  • Pierre Z Tawadros, MD · Cairo University

  • Hassan M Hassan, M.D,FCAI · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-05-31
Completion
2018-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02714725 on ClinicalTrials.gov